Experimental Gilead drug effective in early-stage leukemia trial
May 15, 2013 at 17:59 PM EDT
May 15 (Reuters) - An experimental drug from Gilead Sciences Inc shrank tumors in half of leukemia patients whose cancer had returned, according to an early-stage trial that represents a new foray into oncology by the world's biggest seller of HIV medications.